Labcorp (LH): Beck Mack & Oliver LLC added to its stake +16K shares
Beck Mack & Oliver LLC added to its stake in Labcorp, per its Q4 2025 13F.
- 627K
- Shares reported · +16K vs prior quarter
- 2.9%
- Disclosed portfolio weight
- $157M
- Reported value
- Holdings as of
- Dec 31, 2025
- Filed
- Feb 12, 2026
What stands out in this filing
- 610,845 shares in Q3 2025, 627,037 now (+2.7% in share count).
- Reported at $157M, 2.86% of the portfolio value in this 13F filing.
- 30 other tracked managers reported the same kind of change for Q4 2025.
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: changed a top executive or board member, 6 days earlier (Feb 6, 2026). The first one after it: reported its results, 5 days later (Feb 17, 2026).
- Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 9, 2025, Mark Schroeder, the Executive Vice President and President, Diagnostics Laboratories and Chief Operations Officer of Labcorp Holdings Inc. (the “Company”), notified the Company of his intention to retire, effective on April 1, 2026.”
- Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- CongressDisclosed purchase of LH — reported range $1,001 - $15,000
- CongressDisclosed purchase of LH — reported range $1,001 - $15,000
- Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Labcorp Holdings Inc. (the “Company”) today announced that on February 6, 2026, the Company’s Board of Directors (the “Board”) appointed John H. Sampson, M.D., Ph.D., as a member of the Board, effective February 9, 2026.”
- InsiderOfficer sold ~$24K of LH shares in the open market
- InsiderOfficer sold ~$25K of LH shares in the open market
- InsiderCEO sold ~$1.5M of LH shares in the open market
- CongressDisclosed purchase of LH — reported range $1,001 - $15,000
- InsiderOfficer sold ~$25K of LH shares in the open market
What came next
- Company filing · Form 8-K · ResultsReported its results
- InsiderOfficer sold ~$185K of LH shares in the open market
- InsiderOfficer sold ~$429K of LH shares in the open market
- InsiderOfficer sold ~$156K of LH shares in the open market
- Insider · Their largest sale since 2018CEO sold ~$2.44M of LH shares in the open market
- Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
- 5% stakeThe Vanguard Group reported a passive stake (13G)
- Insider · 2 peopleInsiders: 2 sales (~$660K)
- 5% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
- Company filing · Form 8-K · ResultsReported its results
- InsiderCEO sold ~$1.5M of LH shares in the open market
- InsiderOfficer sold ~$201K of LH shares in the open market
How to read SEC Form 13F-HR
Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.
Full guide: What is an SEC Form 13F?
What else is on file for Labcorp
For Labcorp, OQRO holds 9 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its LH page.
How this filing works
Explore the data
Common questions
What does this filing report about Labcorp (LH) stock?
Beck Mack & Oliver LLC added to its stake in Labcorp, per its Q4 2025 13F. Now 627K shares, $157M reported value, 2.9% of disclosed portfolio.
When did it happen, and when was it made public?
Holdings as of: Dec 31, 2025. Filed: Feb 12, 2026.
What stands out in this filing?
610,845 shares in Q3 2025, 627,037 now (+2.7% in share count). Reported at $157M, 2.86% of the portfolio value in this 13F filing. 30 other tracked managers reported the same kind of change for Q4 2025.
Is this a trade made on a known date?
No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.
Where does this information come from?
From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Labcorp recently?
For Labcorp, OQRO holds 9 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports and 1 fund holdings report (13F) dated in the last 90 days. They are listed on the LH page.
Does this mean LH stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Labcorp
- SEC Form 4Nov 18, 2026
- SEC Form 13F-HRNov 16, 2026
- SEC Form 144Nov 16, 2026
- SEC Form 4Nov 12, 2026
- SEC Form 144Nov 10, 2026
- SEC Form 4Nov 5, 2026
Everything OQRO holds on this company is on its LH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
